What is the optimal duration of antibiotics in common infections?;Quelle est la durée optimale de l'antibiothérapie pour les infections fréquentes?

Revue Medicale Suisse

Volumn 6, Issue 266, 2010, Pages 1901-1905

  Volluz, Sophie Duc ^a   Abbet, Philippe ^a   Troillet, Nicolas ^b  

^a Centre Hospitalier du Centre du Valais   (Switzerland)

^b Institut Central des Hopitaux Valaisans   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; NITROFURANTOIN; QUINOLONE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC THERAPY; COMMUNITY ACQUIRED PNEUMONIA; CYSTITIS; DRUG RESPONSE; HUMAN; INFLAMMATION; REVIEW; SINUSITIS; SKIN INFECTION; TREATMENT DURATION; URINARY TRACT; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG ADMINISTRATION SCHEDULE; HUMANS;

EID: 78049298191     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. * Rice LB. The Maxwell Finland Lecture: For the duration-rational antibiotic administration in the era of antimicrobial resistance and Clostridium difficile. Clin Infect Dis 2008;46:491-6.
2. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America (IDSA)/American Thoracic Society Consensus. Guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl.):S27-S72.
3. Li JZ, Winston LG, Moore DH, Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: A meta-analysis. Am J Med 2007;120:783-90. (Pubitemid 47313349)
4. Marrie TJ, Beecroft MD, Herman-Gnjidic Z. Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis. J Infect 2004;49:302-9.
5. ** Lamy O, Zanetti G, Bille J, et al. Prise en charge ambulatoire et hospitalière de la pneumonie acquise à domicile (PAD). Med Hyg 2004;62:1573-8.
6. Castro-Guardiola A, Viejo-Rodriguez AL, Soler-Simon S, et al. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: A randomized controlled trial. Am J Med 2001;111:367-74.
7. Hitt CM, Nightingale CH, Quintiliani R, et al. Streamlining antimicrobial therapy for lower respiratory tract infections. Clin Infect Dis 1997;24(Suppl.):S231-S7.
8. Beaumont M, Shuster MG. Is an observation period necessary after intravenous antibiotics are changed to oral administration? Am J Med 1999;106:114-6.
9. Aliberti S, Blasi F, Zanaboni AM, Peyrani P, et al. Duration of antibiotic therapy in hospitalized patients with community-acquired pneumonia. Eur Respir J 2010;36:128-34.
10. MiIo G, Katchman E, Paul M, et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst Rev 2005;2:CD 004682.
11. * Gupta K, Hooton TM Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167:2207-12.
12. * Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial. JAMA 2000;283:1583-90.
13. Klausner HA, Brown P, Peterson J, et al. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. Curr Med Res Opin 2007;23:2637-45.
14. Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev 2008;3:CD001535.
15. Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31(Suppl):S68-S78.
16. * Altamini S, Khalil A, Khalaiwi KA, et al. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev 2009;1:CD004872.
17. Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis. A randomized controlled trial. JAMA 2007;298:2487-96.
18. Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: A meta-analysis of randomized trials. Br J Clin Pharmacol 2009;67:161-71.
19. Hepburn MJ, Dooley DP, Skidmore PJ, et al. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 2004;164:1669-74.
20. Stevens DL, Bisno AL, Chambers HF, et al. IDSA practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-406.
21. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. The ProHOSP randomized controlled trial. JAMA 2009;302:1059-66.